Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565).

J Pain Res · 2020 · PMC7695600 · PMID 33262641

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

trend toward significanceno p-value reported

Moreover, although there were no differences between tolperisone groups and placebo in fingers to floor distance or ODI total scores, certain subcategories of the ODI did trend toward significance for the tolperisone 200 mg TID group at day 14.

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.